Updates are available Correction dated 2020-09-20
Click to view Correction: https://doi.org/10.1186/s12944-020-01380-x
-
Authors
Bielecka-Dabrowa, Agata http://orcid.org/0000-0001-6666-3999
Bytyçi, Ibadete
Von Haehling, Stephan
Anker, Stefan
Jozwiak, Jacek
Rysz, Jacek
Hernandez, Adrian V.
Bajraktari, Gani
Mikhalidis, Dimitri P.
Banach, Maciej
- License Information
-
More Information
Article History
Received: 28 June 2019
Accepted: 16 October 2019
First Online: 31 October 2019
Change Date: 20 September 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: ABD, IB, JR, JJ, SvH, and AVH have no conflicts of interest to disclose; DPM has given talks and attended conferences sponsored by MSD, AstraZeneca and Libytec; SDA reports personal fees from Bayer, Boehringer Ingelheim, Vifor, Servier and Novartis, outside the submitted work; MB has served on the speakers bureau of Abbott/Mylan, Abbott Vascular, Actavis, Akcea, Amgen, Biofarm, KRKA, MSD, Sanofi-Aventis, Servier and Valeant, and has served as a consultant to Abbott Vascular, Akcea, Amgen, Daichii Sankyo, Esperion, Lilly, MSD, Resverlogix, Sanofi-Aventis; Grants from Sanofi and Valeant.
